SenesTech, Inc. Announces Closing of $3.95 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

SenesTech intends to use internet proceeds from the registered direct providing for operating funds and common company needs.

H.C. Wainwright & Co. acted as the distinctive placement agent for the featuring.

A shelf registration statement on Sort S-3 (File No. 333-225712) relating to the registered direct giving of the shares of widespread inventory described earlier mentioned was submitted with the Securities and Trade Commission (“SEC”) and was declared efficient on August 24, 2018. The presenting of the shares of frequent stock was produced only by implies of a prospectus dietary supplement and accompanying prospectus that forms a component of the registration statement. Digital copies of the ultimate prospectus health supplement and the accompanying prospectus have been submitted with the SEC and might be acquired from H.C. Wainwright & Co., LLC, 430 Park Avenue, 3rd Floor, New York, NY 10022, by calling (646) 975-6996 or by emailing placements@hcwco.com or at the SEC’s site at http://www.sec.gov.

This push release shall not constitute an present to offer or the solicitation of an offer to get nor shall there be any sale of these securities in any state or jurisdiction in which this kind of offer, solicitation or sale would be illegal prior to registration or qualification underneath the securities legal guidelines of any this sort of point out or jurisdiction.

About SenesTech

SenesTech is changing the design for pest administration by concentrating on a person of the root causes of the difficulty: copy.

ContraPest(R) is an revolutionary technology with an method that targets the reproductive abilities of equally sexes in rat populations, inducing egg reduction in female rats and impairing sperm advancement in males. Making use of a proprietary bait shipping and delivery process, ContraPest(R) is dispensed in a remarkably palatable liquid formulation that promotes sustained intake by rat communities. ContraPest(R) is designed, formulated and dispensed to be small hazard for handlers and non-concentrate on species this sort of as wildlife, livestock and animals, exactly where the active elements split down rapidly.

We consider ContraPest(R) will create a new paradigm in rodent handle, ensuing in a reduced reliance on lethal alternatives. For additional data visit the SenesTech web page at www.senestech.com.

Safe Harbor Assertion

The foregoing paragraphs consist of ahead-on the lookout statements that entail estimates, assumptions, risks and uncertainties. Any statements about our expectations, beliefs, designs, aims, assumptions or future gatherings or functionality are not historic facts and may possibly be ahead-wanting. “Forward-on the lookout statements” could be preceded by words and phrases these kinds of as “may possibly,” “potential,” “plan” or “planned,” “will,” “ought to,” “expected,” “anticipates,” “continue on,” “inevitably,” “believes,” or “projected.” Forward-wanting statements include things like statements relating to the use of the proceeds of the registered direct giving, and the Company’s commercialization of its technology.

Traders ought to not unduly rely on forward-seeking statements. This kind of statements are subject to a multitude of risks and uncertainties that could lead to future situation, activities, or final results to differ materially from all those produced in the forward-wanting statements, including as a end result of numerous components and other dangers, this kind of as marketplace conditionsand other variables identified in the Company’s filings with the Securities and Exchange Commission, which include its once-a-year report on Kind 10-K and quarterly reviews filed on Type 10-Q. All forward-wanting statements communicate only as of the date on which they were made primarily based on management’s assumptions as of these types of date. The Firm does not undertake any obligation to update any forward-looking statements, irrespective of whether as a end result of the receipt of new data, the occurrence of upcoming activities or normally, except as demanded by legislation.

Speak to:

Investors: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC,
602-889-9700, senestech@lythampartners.com

Organization: Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,
928-779-4143

COMTEX_383236828/2471/2021-03-23T11:52:09

Is there a issue with this press release? Make contact with the supply company Comtex at editorial@comtex.com. You can also get in touch with MarketWatch Consumer Services by way of our Shopper Middle.

(C) Copyright 2021 GlobeNewswire, Inc. All legal rights reserved.